Introduction
Because the exact pathogenesis of Alzheimer’s disease (AD) is still unclear, and there is no objective diagnostic criteria and biomarkers, the research and development of innovative therapeutics for AD has always been a great challenge. In recent years, a number of promising research and development projects for Alzheimer’s treatment have failed, which has forced us to reflect on these failures. Alzheimacy believes that the development of Alzheimer’s treatment depends on the in-depth understanding of the pathogenesis of the disease. We will use our integrated technology platform to advance basic research on the pathogenesis and biomarkers of AD. In addition, we are willing to cooperate with scientists or research institutions in the fields of molecular and cell biology, neuropathology, genetics, imaging, and cognitive neuroscience to promote the development of basic research on AD.
Contact Info
Address:
45-1 Ramsey Road, Shirley, New York 11967, USA
New York
11967
United States
New York
11967
United States
Tel:
Website:
https://www.creativebiomart.net/alzheimacy/solutions/basic-research/
Hours of operation
| From | To | From | To | From | To | ||
|---|---|---|---|---|---|---|---|
| Monday | Open | ||||||
| Tuesday | Open | ||||||
| Wednesday | Open | ||||||
| Thursday | Open | ||||||
| Friday | Open | ||||||
| Saturday | Open | ||||||
| Sunday | Open | ||||||
